Hydralyte sales gain traction throughout North America

The Hydration Pharmaceuticals Company (ASX: HPC) CEO Oliver Baker joins Small Caps to discuss the company’s expanding Hydralyte sales throughout North America.

In its March quarterly report, the company revealed Hydralyte sales in North America were up 122% compared to the previous corresponding period.

In the coming months, the company has numerous initiatives planned to drive sales further including product launches and marketing campaigns.

Article:
https://smallcaps.com.au/the-hydration-pharmaceuticals-company-canadian-actress-entrepreneur-brand-ambassador-equity-partner/

For more information on The Hydration Pharmaceuticals Company:
https://smallcaps.com.au/stocks/HPC/

-----------------------

Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.

-----------------------

WEBSITE
https://smallcaps.com.au/

PODCAST
https://smallcaps.com.au/podcast/

SOCIAL MEDIA
Facebook: https://www.facebook.com/SmallCapsASX
Twitter: https://twitter.com/SmallCapsASX
LinkedIn: https://www.linkedin.com/company/small-caps/

NEWSLETTER
https://smallcaps.com.au/subscribe/